FDA Drug Application (202327) for SITAGLIPTIN PHOSPHATE by WATSON LABS INC

Back to FDA Applications sponsored by WATSON LABS INC

Application Number202327
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSITAGLIPTIN PHOSPHATE
Active IngredientSITAGLIPTIN PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient SITAGLIPTIN PHOSPHATE7


Back to FDA Applications sponsored by WATSON LABS INC